作者
Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
发表日期
2013/9
来源
Nature reviews Gastroenterology & hepatology
卷号
10
期号
9
页码范围
553-562
出版商
Nature Publishing Group UK
简介
Worldwide, an estimated 130–170 million people have HCV infection. HCV prevalence is highest in Egypt at >10% of the general population and China has the most people with HCV (29.8 million). Differences in past HCV incidence and current HCV prevalence, together with the generally protracted nature of HCV disease progression, has led to considerable diversity in the burden of advanced liver disease in different countries. Countries with a high incidence of HCV or peak incidence in the recent past will have further escalations in HCV-related cirrhosis and hepatocellular carcinoma (HCC) over the next two decades. Acute HCV infection is difficult to detect because of the generally asymptomatic nature of the disease and the marginalization of at-risk populations. Around 25% of patients with acute HCV infection undergo spontaneous clearance, with increased rates among those with favourable IL28B …
引用总数
201320142015201620172018201920202021202220232024895174174156153132112104866631
学术搜索中的文章
B Hajarizadeh, J Grebely, GJ Dore - Nature reviews Gastroenterology & hepatology, 2013